This study will evaluate the association of non-alcoholic fatty liver disease and coronary artery disease. All patients presenting for coronary angiogram will receive the following examination:

• Transient Elastography and Controlled Attenuation Parameter using the FibroScan
• blood examination including biochemical markers The results of non-invasive liver steatosis and fibrosis measurement are compared with the results of coronary angiogram concerning the presence or absence of coronary artery disease.

Inclusion Criteria:

• Male or female, 18 years and older
• Written consent
• Coronary angiogram planned

Exclusion Criteria:

• Patients with mental diseases
• Pregnancy or lactation
• Ascites